Flurbiprofen: A Nonselective Cyclooxygenase (COX) Inhibitor for Treatment of Noninfectious, Non-necrotizing Anterior Scleritis

References

• Watson PG, Hayreh SS. Scleritis and episcleritis. The B J Ophthalmol. 1976;60:163–191
   PubMed Web of Science ®Google Scholar
• Sims J. Scleritis: presentations, disease associations and management. Postgrad Med J. 2012;88:713–718
   PubMed Web of Science ®Google Scholar
• Heron E, Gutzwiller-Fontaine M, Bourcier T. Scleritis and episcleritis: diagnosis and treatment. Rev Med Interne. 2014;39:577–585
   Web of Science ®Google Scholar
• Katz MS, Chuck RS, Gritz DC. Scleritis and episcleritis. Ophthalmology. 2012;119:1715, e1711
   Web of Science ®Google Scholar
• Kirkwood BJ, Kirkwood RA. Episcleritis and scleritis. Insight. 2010;35:5–8
   PubMedGoogle Scholar
• Wakefield D, Di Girolamo N, Thurau S, et al. Scleritis: immunopathogenesis and molecular basis for therapy. Prog Retin Eye Res. 2013;35:44–62
   PubMed Web of Science ®Google Scholar
• Sainz de la Maza M, Jabbur NS, Foster CS. Severity of scleritis and episcleritis. Ophthalmology. 1994;101:389–396
   PubMed Web of Science ®Google Scholar
• Tuft SJ, Watson PG. Progression of scleral disease. Ophthalmology. 1991;98:467–471
   PubMed Web of Science ®Google Scholar
• Akpek EK, Thorne JE, Qazi FA, et al. Evaluation of patients with scleritis for systemic disease. Ophthalmology. 2004;111:501–506
   PubMed Web of Science ®Google Scholar
• Smith JR, Mackensen F, Rosenbaum JT. Therapy insight: scleritis and its relationship to systemic autoimmune disease. Nat Clin Prac Rheumatol. 2007;3:219–226
   PubMedGoogle Scholar
• Wieringa WG, Wieringa JE, ten Dam-van Loon NH, Los LI. Visual outcome, treatment results, and prognostic factors in patients with scleritis. Ophthalmology. 2013;120:379–386
   PubMed Web of Science ®Google Scholar
• Rachitskaya A, Mandelcorn ED, Albini TA. An update on the cause and treatment of scleritis. Curr Opin Ophthalmol. 2010;21:463–467
   PubMed Web of Science ®Google Scholar
• Machado Dde O, Curi AL, Fernandes RS, et al. Scleritis: clinical characteristics, systemic associations, treatment and outcome in 100 patients. Arq Bras Oftalmol. 2009;72:231–235
   PubMed Web of Science ®Google Scholar
• Albini TA, Rao NA, Smith RE. The diagnosis and management of anterior scleritis. Int Ophthalmol Clin. 2005;45:191–204
   PubMedGoogle Scholar
• Wakefield D, Di Girolamo N, Thurau S, et al. Scleritis: challenges in immunopathogenesis and treatment. Discov Med. 2013;16:153–157
   PubMed Web of Science ®Google Scholar
• Geerts H. Drug evaluation: (R)-flurbiprofen–an enantiomer of flurbiprofen for the treatment of Alzheimer's disease. IDrugs. 2007;10:121–133
   PubMed Web of Science ®Google Scholar
• Sainz de la Maza M, Molina N, Gonzalez-Gonzalez LA, et al. Scleritis therapy. Ophthalmology. 2012;119:51–58
   PubMed Web of Science ®Google Scholar
• Beardsley RM, Suhler EB, Rosenbaum JT, Lin P. Pharmacotherapy of scleritis: current paradigms and future directions. Expert Opin Pharmacother. 2013;14:411–424
   PubMed Web of Science ®Google Scholar
• McMullen M, Kovarik G, Hodge WG. Use of topical steroid therapy in the management of nonnecrotizing anterior scleritis. Can J Ophthalmol. 1999;34:217–221
   PubMed Web of Science ®Google Scholar
• Sohn EH, Wang R, Read R, et al. Long-term, multicenter evaluation of subconjunctival injection of triamcinolone for non-necrotizing, noninfectious anterior scleritis. Ophthalmology. 2011;118:1932–1937
   PubMed Web of Science ®Google Scholar
• Jabs DA. Regional corticosteroids for scleritis. Ophthalmology. 2012;119:2198–2199 e2191; Author reply 2199–200
   PubMed Web of Science ®Google Scholar
• Ali A, Rosenbaum JT. Use of methotrexate in patients with uveitis. Clin Exp Rheumatol. 2010;28:S145–150
   PubMed Web of Science ®Google Scholar
• Kolomeyer AM, Ragam A, Shah K, et al. Mycophenolate mofetil in the treatment of chronic non-infectious, non-necrotizing scleritis. Ocul Immunol Inflamm. 2012;20:113–118
   PubMed Web of Science ®Google Scholar
• Restrepo JP, Molina MP. Successful treatment of severe nodular scleritis with adalimumab. Clin rReumatol. 2010;29:559–561
   PubMed Web of Science ®Google Scholar
• Ragam A, Kolomeyer AM, Fang C, et al. Treatment of chronic, noninfectious, nonnecrotizing scleritis with tumor necrosis factor alpha inhibitors. Ocul Immunol Inflamm. 2013;22:469–477
   PubMed Web of Science ®Google Scholar
• Bielefeld P, Muselier A, Devilliers H, et al. Cotrimoxazole as a treatment for recurrent idiopathic anterior scleritis: a single-center experience in 20 patients. Ocul Immunol Inflamm. 2014;23:184–187
   PubMed Web of Science ®Google Scholar
• Sen HN, Sangave A, Hammel K, et al. Infliximab for the treatment of active scleritis. Canad J Ophthalmol. 2009;44:e9–e12
   PubMedGoogle Scholar
• Abdel-Aziz AA, Al-Badr AA, Hafez GA. Flurbiprofen. In: Profiles Drug Subst Excip Relat Methodol. 2012;37:113–181
   Google Scholar
• Jabs DA, Mudun A, Dunn JP, Marsh MJ. Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol. 2000;130:469–476
   PubMed Web of Science ®Google Scholar
• Tu EY, Culbertson WW, Pflugfelder SC, et al. Therapy of nonnecrotizing anterior scleritis with subconjunctival corticosteroid injection. Ophthalmology. 1995;102:718–724
   PubMed Web of Science ®Google Scholar
• Croasdale CR, Brightbill FS. Subconjunctival corticosteroid injections for nonnecrotizing anterior scleritis. Arch Ophthalmol. 1999;117:966–968
   PubMed Web of Science ®Google Scholar
• Park YH. Sub-tenon triamcinolone acetonide injection in the treatment of scleritis. Am J Ophthalmol. 2010;150:128; author reply 128–129
   PubMed Web of Science ®Google Scholar
• Onal S, Asfuroglu E, Kazokoglu H. Subconjunctival triamcinolone acetonide injection in the treatment of acute noninfectious nonnecrotizing anterior scleritis. Am J Ophthalmol. 2010;149:1012; author reply 1012–1013
   PubMed Web of Science ®Google Scholar
• Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000;130:492–513
   PubMed Web of Science ®Google Scholar
• Piper JM, Ray WA, Daugherty JR, Griffin MR. Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med. 1991;114:735–740
   PubMed Web of Science ®Google Scholar
• Bauer AM, Fiehn C, Becker MD. Celecoxib, a selective inhibitor of cyclooxygenase 2 for therapy of diffuse anterior scleritis. Am J Ophthalmol. 2005;139:1086–1089
   PubMed Web of Science ®Google Scholar